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OpReply to: ‘‘Protective effects of moderate alcohol
consumption on fatty liver: A spurious association?’’To the Editor:
We would like to thank Bell et al. for their comments regarding
our recently published article [1]. They suggested some possible
concerns to be considered carefully.
Concerning the possibility that non-drinkers may not always
be lifetime abstainers, it was difﬁcult to separate former drinkers
from lifetime abstainers based on the questionnaire used in the
study. We recognized this limitation and pointed it out in our
previous study [2], although we were unable to do so in our
recent article due to limited space. It is likely that drinkers are
advised to stop drinking because of fatty liver. Actually, 4% of
men and 15% of women drinking at baseline abstained by the
end of the follow-up. However, we have data regarding
the changes in drinking habits during the observation period;
the longitudinal analysis with the generalized estimating equa-
tion can partly take the changes in the drinking status into
account. Bell et al. also suggested that lifetime abstainers might
have had poor health status. Although we cannot rule out the
possibility that such bias may distort the results, the participants
of our study were generally healthy enough to work and we
suppose that the number of those who had health problems
earlier in their life-course, if any, was small enough not to affect
the statistical analyses.
We cited some articles that suggest the possible mecha-
nisms of the inverse association between alcohol consumption
and fatty liver [1]. Bell et al. also expressed concerns regarding
them. Observational studies may have similar limitations; how-
ever, we also cited an experimental study in mice [3], which is
supposed to be free from those limitations. We cited some
more such articles in our previous study [2], although due to
limited space we were unable to cite all of these in our current
article.
Additionally, Bell et al. mentioned the causal relationship
between alcohol consumption and obesity. However, this
association was not observed in our cohort and rather the reverse
was noted; for example, in men, the body mass index values were
signiﬁcantly lower in the drinkers than in the current non-
drinkers (23.4 ± 2.9 kg/m2 vs. 23.8 ± 3.2 kg/m2, p <0.001) and
the prevalence of obesity was lower in the drinkers than in the
current non-drinkers (26.4% vs. 32.5%, p <0.001). Therefore, there
appears to be no rationale concerning overadjustment bias in our
study. However, we re-calculated the odds ratio for fatty liver in
each category of the average weekly alcohol consumption in men
without adjusting for obesity and found similar results to those
obtained after adjusting for obesity, suggesting that there was
almost no impact of taking obesity into consideration on the
results in our cohort (Fig. 1A).
We thank Bell et al. for presenting their data of the Whitehall
II prospective cohort study demonstrating an association
between a higher alcohol intake and greater odds of fatty liver
using the fatty liver index (FLI) [4]. To compare their results with
ours, we again re-calculated the odds ratio for fatty liver in a
similar manner to the analysis by Bell et al.; that is, we analyzed
with drinking 0.1–69.9 g/week as reference and adjusted for age,
smoking status, and regular exercise. As shown in Fig. 1B, the
non-drinker category had a higher risk for fatty liver than
drinking 0.1–69.9 g/week. Since the non-drinker group was a
mixture of former drinkers and lifetime abstainers, it is difﬁcult
to discuss further concerning this relationship. On the other hand,
higher levels of alcohol intake were not associated with greater
odds of fatty liver in our cohort; it was different from the results
by Bell et al. We are not sure whether the discrepancy is due to
the difference in ethnicity or in the modality to assess fatty liver.
Ultrasonography is more reliable than FLI in assessing fatty liver,
since FLI was developed to predict the presence of fatty liver
diagnosed on ultrasonography [4]. Further studies in different
ethnicities with ultrasonographic assessment would be
warranted.
Finally, we have not stated the safety of alcohol consumption
for all individuals nor encouraged alcohol consumption. In our
paper, we simply described the evidence obtained from a
longitudinal analysis showing that alcohol consumption is
inversely associated with fatty liver in a major part of the general
population. However, it is hard to claim a causal relationship
between alcohol consumption and fatty liver, since our study
was observational and not interventional. Moreover, although
we hypothesize that alcohol may have a somewhat protective
effect against fatty liver within a certain threshold and that thisJournal of Hepatology 2015 vol. 62 j 1204–1218 1211
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threshold may differ in each person, at present, we cannot specify
what distinguishes individuals who develop fatty liver as a result
of alcohol consumption from those who do not.
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Fig. 1. Odds ratio for fatty liver in each category of the average weekly alcohol consumption in men. (A) The odds ratio for fatty liver was analyzed with non-drinkers
as reference and adjusted for smoking status and regular exercise; or (B) analyzed with drinking 0.1–69.9 g/week as reference and adjusted for age, smoking status, and
regular exercise.
Non-alcoholic fatty liver disease: Severity of ﬁbrosis and its
relationships with clinical and biological variables
To the Editor:
The paper of Petta et al. [1] throws new light on an important
issue. Indeed, no data were previously available on the impact
of the severity of liver damage on cardiac function and structural
remodeling for patients affected by NAFLD. Moreover, this study
partially clariﬁes the relationship between visceral adiposity and
severe liver ﬁbrosis in these patients. However, some comments
might be useful for a deeper interpretation of these ﬁndings. In
fact, some of our previous work shows that various circulating
molecules (i.e., adiponectin, TGF b1, e-selectin, and endothelin)
play a signiﬁcant role in left ventricular remodeling [2,3], pro-
gression of renal function impairment [4,5], and in the manifesta-
tion of left ventricular dysfunction [6–8] in central obese
subjects.
A recent study by Akyildiz et al. [9] found that higher serum
levels of the hormone FGF 21 were associated with larger epicar-
dial fat thickness in obese women. All the above-mentioned
molecules are related to both inﬂammation and ﬁbrosis at var-
ious levels. Thus, these manuscripts could have been discussed
in the paper. Nonetheless, these data will be useful for future
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